Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 20435207)

Published in Am Heart J on May 01, 2010

Authors

Michael Gotzmann1, Michael Lindstaedt, Waldemar Bojara, Andreas Mügge, Alfried Germing

Author Affiliations

1: BG-Kliniken Bergmannsheil, Medical Clinic II, Ruhr-University Bochum, Germany. michael_gotzmann@web.de <michael_gotzmann@web.de>

Articles by these authors

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J (2006) 4.69

Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study. Eur Heart J (2003) 2.36

Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart (2009) 2.13

Postablation asymptomatic cerebral lesions: long-term follow-up using magnetic resonance imaging. Heart Rhythm (2011) 1.78

Acute safety and efficacy of a novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation. J Cardiovasc Electrophysiol (2013) 1.74

Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation (2004) 1.73

Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses--valve-in-valve technique. Catheter Cardiovasc Interv (2010) 1.61

Selective cyclo-oxygenase-2 inhibition with parecoxib acutely impairs endothelium-dependent vasodilatation in patients with essential hypertension. J Hypertens (2003) 1.56

Utility of esophageal temperature monitoring during pulmonary vein isolation for atrial fibrillation using duty-cycled phased radiofrequency ablation. J Cardiovasc Electrophysiol (2010) 1.46

Modifying effects of the R389G beta1-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea. Clin Sci (Lond) (2006) 1.44

Heart failure in severe aortic valve stenosis: prognostic impact of left ventricular ejection fraction and mean gradient on outcome after transcatheter aortic valve implantation. Eur J Heart Fail (2012) 1.44

Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Thromb Res (2006) 1.43

Total atrial conduction time assessed by tissue doppler imaging (PA-TDI Interval) to predict early recurrence of persistent atrial fibrillation after successful electrical cardioversion. J Cardiovasc Electrophysiol (2013) 1.42

Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J (2006) 1.38

Human histopathology of electroanatomic mapping after cooled-tip radiofrequency ablation to treat ventricular tachycardia in remote myocardial infarction. J Cardiovasc Electrophysiol (2005) 1.29

Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain (2007) 1.25

Duloxetine and hyponatremia: a report of 5 cases. J Clin Psychopharmacol (2007) 1.16

Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C. FEBS J (2005) 1.15

Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation (2004) 1.11

Long-term outcome of patients with moderate and severe prosthetic aortic valve regurgitation after transcatheter aortic valve implantation. Am J Cardiol (2012) 1.10

Occlusion of pseudoaneurysms using human or bovine thrombin using contrast-enhanced ultrasound guidance. Am J Cardiol (2004) 1.04

[Health care quality: medication and prevention in patients with and without coronary heart disease]. Med Klin (Munich) (2004) 1.02

Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI. Mov Disord (2007) 0.99

Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. Eur Heart J (2005) 0.98

How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification. Thromb Haemost (2008) 0.96

Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail (2008) 0.95

Catheter ablation of electrical storm in a collaborative hospital network. Am J Cardiol (2011) 0.95

Fatal prosthetic valve endocarditis of the CoreValve ReValving System. Clin Res Cardiol (2011) 0.94

Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am Heart J (2011) 0.93

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. BMC Med (2011) 0.93

Validation of coronary flow reserve measurements by thermodilution in clinical practice. Eur Heart J (2004) 0.92

Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. J Cardiovasc Electrophysiol (2015) 0.91

Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of beta2-adrenergic receptor polymorphisms. BMC Med (2007) 0.91

Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting. J Cardiovasc Pharmacol (2010) 0.91

Clinical, genetic, and cardiac magnetic resonance imaging findings in primary desminopathies. Neuromuscul Disord (2008) 0.90

Long-term sinus rhythm stability after intraoperative ablation of permanent atrial fibrillation. Pacing Clin Electrophysiol (2009) 0.89

Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens (2004) 0.89

Intra-operative cooled-tip radiofrequency linear atrial ablation to treat permanent atrial fibrillation. Eur Heart J (2007) 0.89

Hormonal status modulates circulating endothelial progenitor cells. Clin Res Cardiol (2007) 0.89

Severity of mitral regurgitation may be underestimated in the presence of a left atrial myxoma. J Heart Valve Dis (2006) 0.88

Images in cardiology: Vieussens' ring. Clin Cardiol (2003) 0.88

One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis. Am J Cardiol (2011) 0.87

[Prediction of coronary artery stenosis by measurement of total plaque area and thickness versus intima media thickness of the carotid artery]. Herz (2015) 0.87

Implantation of the CoreValve self-expanding valve prosthesis via a subclavian artery approach: a case report. Clin Res Cardiol (2009) 0.86

Adenosine-induced maximal coronary hyperemia for myocardial fractional flow reserve measurements: comparison of administration by femoral venous versus antecubital venous access. Clin Res Cardiol (2009) 0.86

The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile. BMC Cardiovasc Disord (2008) 0.85

Treatment of persistent atrial fibrillation using phased radiofrequency ablation technology. Expert Rev Cardiovasc Ther (2011) 0.85

Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. Eur J Med Res (2007) 0.85

Normal values for longitudinal function of the right ventricle in healthy women >70 years of age. Eur J Echocardiogr (2010) 0.85

Catheter ablation of electrical storm. Expert Rev Cardiovasc Ther (2011) 0.85

Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation (2005) 0.84

Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements. Am Heart J (2006) 0.84

Large femoral aneurysm as a late complication after vessel closure device application. Clin Res Cardiol (2006) 0.83

Shift in the pattern of autonomic atrial innervation in subjects with persistent atrial fibrillation. Heart Rhythm (2011) 0.83

Dosimetric measurements in isolated human coronary arteries: comparison of commercially available iridium(192) with strontium/yttrium(90) emitters. Circulation (2002) 0.83

From pressure overload to volume overload: aortic regurgitation after transcatheter aortic valve implantation. Am Heart J (2012) 0.83

Reaction patterns of the tracheobronchial wall to implanted noncovered metal stents. Chest (2005) 0.83

Correlation between total atrial conduction time estimated via tissue Doppler imaging (PA-TDI Interval), structural atrial remodeling and new-onset of atrial fibrillation after cardiac surgery. J Cardiovasc Electrophysiol (2013) 0.81

Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis. Catheter Cardiovasc Interv (2011) 0.81

How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses? Int J Cardiol (2007) 0.81

What the cardiac surgeon needs to know prior to aortic valve surgery: impact of echocardiography. Eur J Cardiothorac Surg (2009) 0.81

Increased preoperative serum apoptosis marker fas ligand correlates with histopathology and new-onset of atrial fibrillation in patients after cardiac surgery. J Cardiovasc Electrophysiol (2013) 0.81

Clinical outcome following conservative vs revascularization therapy in patients with stable coronary artery disease and borderline fractional flow reserve measurements. Clin Cardiol (2010) 0.81

Single-center experience with the On-X prosthetic heart valve between 1996 and 2005. J Heart Valve Dis (2007) 0.81